A potential side effect added to Spinraza label
The European label of Spinraza will soon list a new potential side effect: hydrocephalus.
Category: Updates
A potential side effect added to Spinraza label
The European label of Spinraza will soon list a new potential side effect: hydrocephalus.
Belgium and the Netherlands okay Spinraza treatment
Spinraza will be available in Belgium and the Netherlands starting 1 August 2018.
Belgium and the Netherlands okay Spinraza treatment
Spinraza will be available in Belgium and the Netherlands starting 1 August 2018.
Biogen update on European access to Spinraza
Here is an update on reimbursed access to Spinraza treatment in the Europe and Middle East region.
Biogen update on European access to Spinraza
Here is an update on reimbursed access to Spinraza treatment in the Europe and Middle East region.
Risdiplam update from Roche
On 5th July Roche sent us the following information, as per our request to be kept up to date on their current research regarding the RG7916 development programme which will now be known as “risdiplam”. The programme has now reached a number of key milestones. They also announced a new study called RAINBOWFISH which will…
Risdiplam update from Roche
On 5th July Roche sent us the following information, as per our request to be kept up to date on their current research regarding the RG7916 development programme which will now be known as “risdiplam”. The programme has now reached a number of key milestones. They also announced a new study called RAINBOWFISH which will…